Jun Liao

机构：Fujian University of Traditional Chinese Medicine, Sun Yat-sen University, China Pharmaceutical University, Endocrine Society, Henan Provincial People's Hospital, Sun Yat-sen University Cancer Center · ORCID：0000-0002-2017-5065

发表论文 67 篇 · 总被引 385 次 · h-index 10

代表论文

• Sacituzumab tirumotecan in advanced non-small-cell lung cancer with or without EGFR mutations: phase 1/2 and phase 2 trials (2025 · Nature Medicine · 被引 47)
• Artificial intelligence-assisted detection of nasopharyngeal carcinoma on endoscopic images: a national, multicentre, model development and validation study (2025 · The Lancet Digital Health · 被引 10)
• A gain-of-function mutation in ATP6V0A4 drives primary distal renal tubular alkalosis with enhanced V-ATPase activity (2025 · Journal of Clinical Investigation · 被引 8)
• The Clinical Study of Intratumoral and Peritumoral Radiomics Based on DCE-MRI for HER-2 Positive and Low Expression Prediction in Breast Cancer (2024 · Breast Cancer Targets and Therapy · 被引 5)
• EGFR activation disrupts immunotherapy response via SHP2-mediated suppression of tumor-intrinsic response to IFN-γ (2026 · Journal of Clinical Investigation · 被引 3)
• Specifying the choice of EGFR-TKI based on brain metastatic status for advanced NSCLC with EGFR p.L861Q mutation (2024 · Neoplasia · 被引 3)